These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 28140325)

  • 61. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gut Microbiota-Dependent Modulation of Energy Metabolism.
    Heiss CN; Olofsson LE
    J Innate Immun; 2018; 10(3):163-171. PubMed ID: 29131106
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Muscle wasting: the gut microbiota as a new therapeutic target?
    Bindels LB; Delzenne NM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2186-90. PubMed ID: 23831839
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.
    Jayasinghe TN; Chiavaroli V; Holland DJ; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2016; 6():15. PubMed ID: 26925392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
    Lim YY; Lee YS; Ooi DSQ
    Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategies to increase the efficacy of using gut microbiota for the modulation of obesity.
    Li J; Riaz Rajoka MS; Shao D; Jiang C; Jin M; Huang Q; Yang H; Shi J
    Obes Rev; 2017 Nov; 18(11):1260-1271. PubMed ID: 28742949
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
    Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
    BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diet Alters Micronutrient Pathways in the Gut and Placenta that Regulate Fetal Growth and Development in Pregnant Mice.
    Palladino E; Van Mieghem T; Connor KL
    Reprod Sci; 2021 Feb; 28(2):447-461. PubMed ID: 32886339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota].
    Kimura I
    Yakugaku Zasshi; 2014; 134(10):1037-42. PubMed ID: 25274213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?
    Musso G; Gambino R; Cassader M
    Diabetes Care; 2010 Oct; 33(10):2277-84. PubMed ID: 20876708
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.
    Delzenne NM; Neyrinck AM; Cani PD
    Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21995448
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short chain fatty acids in human gut and metabolic health.
    Blaak EE; Canfora EE; Theis S; Frost G; Groen AK; Mithieux G; Nauta A; Scott K; Stahl B; van Harsselaar J; van Tol R; Vaughan EE; Verbeke K
    Benef Microbes; 2020 Sep; 11(5):411-455. PubMed ID: 32865024
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drugging the gut microbiota: toward rational modulation of bacterial composition in the gut.
    Altamura F; Maurice CF; Castagner B
    Curr Opin Chem Biol; 2020 Jun; 56():10-15. PubMed ID: 31678829
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gut microbiota, nutrient sensing and energy balance.
    Duca FA; Lam TK
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():68-76. PubMed ID: 25200299
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health.
    Donovan SM
    Gut Microbes; 2017 Mar; 8(2):75-81. PubMed ID: 28282253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.